Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats

被引:114
作者
Mancini, FP
Lanni, A
Sabatino, L
Moreno, M
Giannino, A
Contaldo, F
Colantuoni, V
Goglia, F
机构
[1] Univ Sannio, Fac Sci Matemat Fis & Nat, I-82100 Benevento, Italy
[2] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy
[3] Univ Naples 2, Dipartimento Sci Vita, I-81100 Caserta, Italy
[4] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, I-80131 Naples, Italy
[5] Univ Naples Federico II, Dipartimento Fisiol Gen & Ambientale, I-80134 Naples, Italy
关键词
fibrate; obesity; fatty acid; peroxisome; mitochondrion; liver;
D O I
10.1016/S0014-5793(01)02146-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrates are hypolipidemic drugs that activate the peroxisome proliferator-activated receptors, Since fibrates may also increase energy expenditure, me investigated whether fenofibrate (FF) had this effect in diet-induced obese rats. A 2-month administration of a high-fat palatable diet to adult rats increased body weight by 25% and white adipose mass by 163% compared with a standard diet. These effects mere prevented by FF, both when administered for the 2 months of high-fat feeding and when given for only the second month. Consequently, FF-treated rats had a final body weight and white adipose tissue mass similar to untreated animals on the standard diet. FF also increased resting metabolic rate, hepatic peroxisomal and mitochondrial palmitoyl-dependent oxygen uptake and mRNA levels of acyl-CoA oxidase and lipoprotein lipase, Finally, FF lowered mRNA levels of uncoupling protein-2 and did not affect mitochondrial respiration in skeletal muscle. Therefore, FF seems to act as a weight-stabilizer mainly through its effect on liver metabolism (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 32 条
[1]   Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].
Auboeuf, D ;
Rieusset, J ;
Fajas, L ;
Vallier, P ;
Frering, V ;
Riou, JP ;
Staels, P ;
Auwerx, J ;
Laville, M ;
Vidal, H .
DIABETES, 1997, 46 (08) :1319-1327
[2]   Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight [J].
Chaput, E ;
Saladin, R ;
Silvestre, M ;
Edgar, AD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (02) :445-450
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]   Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes [J].
Cortez-Pinto, H ;
Lin, HZ ;
Yang, SQ ;
Da Costa, SO ;
Diehl, AM .
GASTROENTEROLOGY, 1999, 116 (05) :1184-1193
[5]   Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis [J].
Costet, P ;
Legendre, C ;
Moré, J ;
Edgar, A ;
Galtier, P ;
Pineau, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29577-29585
[6]   Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].
Desvergne, B ;
Wahli, W .
ENDOCRINE REVIEWS, 1999, 20 (05) :649-688
[7]   Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma [J].
DeVos, P ;
Lefebvre, AM ;
Miller, SG ;
GuerreMillo, M ;
Wong, K ;
Saladin, R ;
Hamann, LG ;
Staels, B ;
Briggs, MR ;
Auwerx, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1004-1009
[8]  
Estabrook R.W., 1967, METHODS ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
[9]   Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia [J].
Fleury, C ;
Neverova, M ;
Collins, S ;
Raimbault, S ;
Champigny, O ;
LeviMeyrueis, C ;
Bouillaud, F ;
Seldin, MF ;
Surwit, RS ;
Ricquier, D ;
Warden, CH .
NATURE GENETICS, 1997, 15 (03) :269-272
[10]  
Froyland L, 1997, J LIPID RES, V38, P1851